14-day Premium Trial Subscription Try For FreeTry Free
$2.64
+0.145 (+5.82%)
At Close: Apr 25, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $2.36 $7.67 Thursday, 25th Apr 2024 BPTH stock ended at $2.64. This is 5.82% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 16.50% from a day low at $2.36 to a day high of $2.75.
90 days $0.352 $7.67
52 weeks $0.320 $7.67

Historical Bio-Path Holdings prices

Date Open High Low Close Volume
Oct 25, 2023 $0.659 $0.689 $0.590 $0.627 373 742
Oct 24, 2023 $0.625 $0.700 $0.560 $0.690 1 360 085
Oct 23, 2023 $0.651 $0.740 $0.620 $0.625 1 320 582
Oct 20, 2023 $0.500 $0.720 $0.466 $0.688 3 074 989
Oct 19, 2023 $0.540 $0.549 $0.490 $0.508 924 111
Oct 18, 2023 $0.573 $0.660 $0.500 $0.568 1 931 845
Oct 17, 2023 $0.640 $0.660 $0.549 $0.620 2 864 886
Oct 16, 2023 $0.638 $0.80 $0.540 $0.680 5 336 227
Oct 13, 2023 $0.89 $1.08 $0.620 $0.750 122 697 851
Oct 12, 2023 $0.380 $0.427 $0.365 $0.394 347 535
Oct 11, 2023 $0.375 $0.380 $0.365 $0.370 43 507
Oct 10, 2023 $0.360 $0.380 $0.346 $0.365 58 430
Oct 09, 2023 $0.370 $0.370 $0.337 $0.357 31 437
Oct 06, 2023 $0.363 $0.370 $0.320 $0.370 28 257
Oct 05, 2023 $0.380 $0.380 $0.361 $0.362 18 137
Oct 04, 2023 $0.370 $0.370 $0.340 $0.355 60 362
Oct 03, 2023 $0.380 $0.380 $0.365 $0.370 24 745
Oct 02, 2023 $0.376 $0.390 $0.370 $0.379 16 931
Sep 29, 2023 $0.390 $0.400 $0.360 $0.370 90 885
Sep 28, 2023 $0.367 $0.380 $0.350 $0.367 199 928
Sep 27, 2023 $0.370 $0.400 $0.360 $0.361 11 625
Sep 26, 2023 $0.360 $0.400 $0.360 $0.369 20 797
Sep 25, 2023 $0.395 $0.400 $0.360 $0.360 52 809
Sep 22, 2023 $0.363 $0.385 $0.363 $0.382 31 617
Sep 21, 2023 $0.419 $0.419 $0.360 $0.378 62 199
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT